PharmaCyte Biotech, Inc. Compensation Agreements
4 Contracts & Agreements
- Amended and Restated Executive Compensation Agreement, dated May 8, 2022, between Carlos A. Trujillo and the Company (Filed With SEC on July 28, 2022)
- Amended and Restated Executive Compensation Agreement, dated May 8, 2022, between Kenneth L. Waggoner and the Company (Filed With SEC on July 28, 2022)
- Amendment No. 3, dated as of October 14, 2020, to Executive Compensation Agreement between Gerald W. Crabtree and the Company (Filed With SEC on October 16, 2020)
- AMENDMENTNo. 2 TO executive Compensation AGREEMENT (Filed With SEC on March 13, 2017)